1. Home
  2. TEVA vs SYF Comparison

TEVA vs SYF Comparison

Compare TEVA & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • SYF
  • Stock Information
  • Founded
  • TEVA 1901
  • SYF 1932
  • Country
  • TEVA Israel
  • SYF United States
  • Employees
  • TEVA N/A
  • SYF N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • SYF Finance: Consumer Services
  • Sector
  • TEVA Health Care
  • SYF Finance
  • Exchange
  • TEVA Nasdaq
  • SYF Nasdaq
  • Market Cap
  • TEVA 18.4B
  • SYF 20.3B
  • IPO Year
  • TEVA N/A
  • SYF N/A
  • Fundamental
  • Price
  • TEVA $15.38
  • SYF $52.94
  • Analyst Decision
  • TEVA Strong Buy
  • SYF Buy
  • Analyst Count
  • TEVA 6
  • SYF 21
  • Target Price
  • TEVA $24.00
  • SYF $65.25
  • AVG Volume (30 Days)
  • TEVA 11.7M
  • SYF 5.0M
  • Earning Date
  • TEVA 05-07-2025
  • SYF 04-23-2025
  • Dividend Yield
  • TEVA N/A
  • SYF 1.90%
  • EPS Growth
  • TEVA N/A
  • SYF 64.74
  • EPS
  • TEVA N/A
  • SYF 8.55
  • Revenue
  • TEVA $16,544,000,000.00
  • SYF $9,392,000,000.00
  • Revenue This Year
  • TEVA $5.31
  • SYF $102.56
  • Revenue Next Year
  • TEVA $1.18
  • SYF $6.13
  • P/E Ratio
  • TEVA N/A
  • SYF $6.16
  • Revenue Growth
  • TEVA 4.41
  • SYF 22.58
  • 52 Week Low
  • TEVA $12.51
  • SYF $39.67
  • 52 Week High
  • TEVA $22.80
  • SYF $70.93
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 38.74
  • SYF 37.57
  • Support Level
  • TEVA $15.28
  • SYF $52.50
  • Resistance Level
  • TEVA $15.80
  • SYF $55.25
  • Average True Range (ATR)
  • TEVA 0.52
  • SYF 1.70
  • MACD
  • TEVA -0.01
  • SYF 0.35
  • Stochastic Oscillator
  • TEVA 30.41
  • SYF 36.60

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

Share on Social Networks: